WeVote
Log In

Bill

Bill

HD 4113

An Act relative to the regulation of Delta-9 THC

194th Legislature (2025-2026) Introduced by Brad Jones and 1 co-sponsor

The bill requires the Cannabis Control Commission to license and regulate all Delta-9 THC products in Massachusetts, from any source, with safety, labeling, and advertising rules.

Senate concurred
0
WeVote Research Nonpartisan
Bill Summary · HD 4113

comprehensive summary: HD 4113 — An Act relative to the regulation of Delta-9 THC

Overview

HD 4113, introduced February 27, 2025, seeks to regulate Delta-9 THC products (the psychoactive component of cannabis) across the Commonwealth of Massachusetts. The bill assigns primary regulatory authority to the Cannabis Control Commission (CCC) for all Delta-9 THC products, regardless of whether they originate from marijuana or hemp. The Senate has concurred with the bill as part of its legislative process.

Key definitions

  • Delta-9 THC: The chemical compound in cannabis responsible for psychoactive effects, defined for the bill as the target of regulation regardless of concentration.
  • Delta-9 THC Products: Any product containing Delta-9 THC intended for human consumption, including edibles, concentrates, tinctures, oils, or other consumables, whether derived from cannabis or hemp.

Regulatory framework and scope

  • Regulatory Authority: The CCC shall regulate, license, and oversee all Delta-9 THC products in the Commonwealth, irrespective of origin (marijuana or hemp).
  • Licensing Requirement: No person may manufacture, distribute, or sell a Delta-9 THC product in Massachusetts unless licensed and registered with the CCC.
  • Standards and Rules: The CCC must establish rules on:
    • Product safety and testing (including Delta-9 THC concentration levels)
    • Packaging and labeling (clear Delta-9 THC content, serving sizes, safety warnings, etc.)
    • Licensing for producers, manufacturers, distributors, and retailers
    • Advertising/marketing restrictions to protect minors and public health
  • Enforcement: The CCC may impose fines, and suspend or revoke licenses for violations.

Expanded regulatory authority

  • The bill adds a new subsection to an existing chapter confirming the CCC’s authority to regulate all cannabis-related products, including Delta-9 THC products, regardless of whether they originate from marijuana or hemp, to ensure safety and compliance with state laws.

Oversight, reporting, and transparency

  • Annual Report (Section 8A): The CCC must submit an annual report to the clerks of the House and Senate detailing:
    • Status of Delta-9 THC product regulation
    • Number of licenses issued
    • Volume of Delta-9 THC products sold
    • Public health concerns or issues identified
    • Recommendations for regulatory improvements

Transition and compliance timeline

  • Transition Period: All Delta-9 THC products in circulation at the time of enactment that do not comply with the new regulatory framework have at least 180 days to come into compliance with CCC licensing and regulatory requirements.
  • Effective Date: The act becomes effective on the first day of the month following 90 days after passage.

Implications and who is affected

  • Businesses: Manufacturers, distributors, retailers, and testers of Delta-9 THC products must obtain CCC licenses and comply with new standards.
  • Public Health: Enhanced safety testing, labeling, serving-size information, and warnings aim to protect consumers.
  • Consumers: Greater transparency on product contents and dosing; potential shifts in availability and product formats due to licensing and regulatory requirements.

Legislative status and process

  • Status: Senate concurred (as of the latest action).
  • Committee action: Referred to the House Committee on Cannabis Policy on the same date as enactment, reflecting a joint review path before enactment (if passed into law).

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.